1 00:00:10,810 --> 00:00:07,929 space in the international space station 2 00:00:13,450 --> 00:00:10,820 offers researchers like me an 3 00:00:16,119 --> 00:00:13,460 opportunity to find the key variables to 4 00:00:18,480 --> 00:00:16,129 crystal growth my experiment is unique 5 00:00:21,400 --> 00:00:18,490 from other protein crystal growth 6 00:00:24,310 --> 00:00:21,410 experiments in that rather than getting 7 00:00:26,320 --> 00:00:24,320 large single crystals I'm interested in 8 00:00:28,350 --> 00:00:26,330 crystal and suspensions and these 9 00:00:32,530 --> 00:00:28,360 crystal and suspensions have 10 00:00:36,040 --> 00:00:32,540 applications such as manufacturing drug 11 00:00:38,860 --> 00:00:36,050 delivery formulation storage these are 12 00:00:42,850 --> 00:00:38,870 all problems of delivering these 13 00:00:44,740 --> 00:00:42,860 monoclonal antibody therapeutics one of 14 00:00:46,510 --> 00:00:44,750 the big problems with monoclonal 15 00:00:48,190 --> 00:00:46,520 antibodies even though they're very good 16 00:00:53,410 --> 00:00:48,200 drugs and they've been approved for 17 00:00:57,389 --> 00:00:53,420 cancer multiple sclerosis osteoporosis a 18 00:01:00,670 --> 00:00:57,399 number of serious life-threatening 19 00:01:04,270 --> 00:01:00,680 diseases is that they're very insoluble 20 00:01:05,920 --> 00:01:04,280 and so they're difficult to deliver one 21 00:01:08,590 --> 00:01:05,930 of the big problems is is that they 22 00:01:11,410 --> 00:01:08,600 usually have to be given as a constant 23 00:01:13,780 --> 00:01:11,420 infusion in a hospital setting over 24 00:01:17,440 --> 00:01:13,790 several hours and this impacts not only 25 00:01:19,750 --> 00:01:17,450 the patient but as a big impact on 26 00:01:21,430 --> 00:01:19,760 caregivers and we're hoping that we 27 00:01:23,920 --> 00:01:21,440 could come up with a crystal and 28 00:01:26,980 --> 00:01:23,930 suspension that you can take as a single 29 00:01:30,039 --> 00:01:26,990 injection in a doctor's office not only 30 00:01:33,100 --> 00:01:30,049 reducing the cost but but reducing the 31 00:01:36,820 --> 00:01:33,110 the time and pain and effort that a 32 00:01:39,940 --> 00:01:36,830 patient and caregivers have to do to 33 00:01:43,120 --> 00:01:39,950 deliver these products so where are we 34 00:01:45,730 --> 00:01:43,130 with that we on earth or in the process 35 00:01:47,560 --> 00:01:45,740 of making concentrated crystal and 36 00:01:50,200 --> 00:01:47,570 suspensions and we're hoping that 37 00:01:52,469 --> 00:01:50,210 microgravity because we get reduced 38 00:01:55,539 --> 00:01:52,479 sedimentation that we get reduced 39 00:01:57,730 --> 00:01:55,549 convection currents and reduce molecular 40 00:02:02,289 --> 00:01:57,740 motion that this will translate into 41 00:02:04,480 --> 00:02:02,299 larger pure more uniform suspensions and 42 00:02:06,160 --> 00:02:04,490 i want to emphasize uniform because for 43 00:02:09,210 --> 00:02:06,170 drug delivery it's very important that 44 00:02:13,110 --> 00:02:09,220 you have each individual particle 45 00:02:16,410 --> 00:02:13,120 has a predictable dissolution rate to 46 00:02:19,410 --> 00:02:16,420 make our drugs as effective as unsafe as 47 00:02:25,050 --> 00:02:19,420 possible our experiment has flown on 48 00:02:27,840 --> 00:02:25,060 SpaceX 3 as well as space X 6 from space 49 00:02:30,690 --> 00:02:27,850 x3 we're very happy to say that we got 50 00:02:33,060 --> 00:02:30,700 crystals that were larger in higher 51 00:02:35,490 --> 00:02:33,070 yield this was our proof of concept 52 00:02:38,730 --> 00:02:35,500 flight and we're very happy to see that 53 00:02:40,440 --> 00:02:38,740 this really mimicked the results that we 54 00:02:42,360 --> 00:02:40,450 had gotten from our earlier space 55 00:02:44,699 --> 00:02:42,370 shuttle missions and this was the 56 00:02:47,010 --> 00:02:44,709 predictable results we were hoping for 57 00:02:50,370 --> 00:02:47,020 and it gives us the confidence to go 58 00:02:52,650 --> 00:02:50,380 forward we just recently flown on SpaceX 59 00:02:54,600 --> 00:02:52,660 six and we got crystals back from that 60 00:02:57,150 --> 00:02:54,610 we're in the process of analyzing that 61 00:03:00,840 --> 00:02:57,160 and we're looking forward to SpaceX 9 62 00:03:03,390 --> 00:03:00,850 and SpaceX 9 we hope that we can finally 63 00:03:05,550 --> 00:03:03,400 make crystals and crystal and 64 00:03:08,850 --> 00:03:05,560 suspensions in the quantity that we need 65 00:03:11,310 --> 00:03:08,860 to do the analysis that we want to do to 66 00:03:14,240 --> 00:03:11,320 really figure out what are the key 67 00:03:16,979 --> 00:03:14,250 variables for making really high quality 68 00:03:20,130 --> 00:03:16,989 preparation suitable for pharmaceutical 69 00:03:22,830 --> 00:03:20,140 applications and I have to say that I 70 00:03:24,780 --> 00:03:22,840 guess surprises a lot of people because 71 00:03:26,009 --> 00:03:24,790 i never get exactly what i'm thinking 72 00:03:28,560 --> 00:03:26,019 i'm going to get from these experiments 73 00:03:30,720 --> 00:03:28,570 and I always learn from that I always 74 00:03:32,910 --> 00:03:30,730 tell people that I've learned how better 75 00:03:35,190 --> 00:03:32,920 to grow crystals on earth by growing in 76 00:03:37,350 --> 00:03:35,200 the microgravity because the focus of 77 00:03:41,100 --> 00:03:37,360 the efforts that I have to put in to 78 00:03:43,920 --> 00:03:41,110 make these experiments work forces me 79 00:03:45,870 --> 00:03:43,930 and forces our team to focus on the